Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 533

1.

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.

Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD Jr, Dores GM, Gilbert ES.

J Natl Cancer Inst. 2005 Sep 21;97(18):1354-65.

PMID:
16174857
2.

Risk of second malignant neoplasms among long-term survivors of testicular cancer.

Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni JF Jr, Boice JD Jr.

J Natl Cancer Inst. 1997 Oct 1;89(19):1429-39.

PMID:
9326912
3.

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.

Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E.

Br J Cancer. 2010 Jan 5;102(1):220-6. doi: 10.1038/sj.bjc.6605435. Epub 2009 Nov 24.

4.

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB.

J Clin Oncol. 2007 Apr 20;25(12):1489-97. Epub 2007 Mar 19.

PMID:
17372278
5.

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB.

J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. Epub 2007 Oct 30.

PMID:
17971527
6.

Treatment-associated leukemia following testicular cancer.

Travis LB, Andersson M, Gospodarowicz M, van Leeuwen FE, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleijfer DT, Clarke EA, Boice JD Jr, Stovall M, Gilbert E.

J Natl Cancer Inst. 2000 Jul 19;92(14):1165-71.

PMID:
10904090
7.

Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.

Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.

J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

PMID:
19066271
8.

Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.

Richiardi L, Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P.

Int J Cancer. 2007 Feb 1;120(3):623-31.

9.

Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.

J Clin Oncol. 2013 Oct 20;31(30):3807-14. doi: 10.1200/JCO.2013.50.3409. Epub 2013 Sep 16.

10.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

11.

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.

van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2007 Oct 1;25(28):4370-8.

PMID:
17906202
12.

Incidence of second cancers in patients treated for Hodgkin's disease.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.

J Natl Cancer Inst. 1995 May 17;87(10):732-41.

PMID:
7563150
13.

Solid cancer incidence in atomic bomb survivors: 1958-1998.

Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K.

Radiat Res. 2007 Jul;168(1):1-64.

PMID:
17722996
14.

Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.

Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M, Travis LB.

J Clin Oncol. 2002 Aug 15;20(16):3484-94.

PMID:
12177110
15.

Noncancer causes of death in survivors of testicular cancer.

Fosså SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, Storm H, Hall P, Holowaty E, Andersen A, Joensuu H, Andersson M, Kaijser M, Gospodarowicz M, Cohen R, Pukkala E, Travis LB.

J Natl Cancer Inst. 2007 Apr 4;99(7):533-44.

PMID:
17405998
16.

Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.

van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2006 Jan 20;24(3):467-75.

PMID:
16421423
17.

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium.

J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6.

PMID:
10433620
18.

Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.

McCredie M, Macfarlane GJ, Bell J, Coates M.

Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):155-60.

19.

Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.

Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF Jr.

J Natl Cancer Inst. 2007 Jan 3;99(1):24-31.

PMID:
17202110
20.

Lifetime risks of common cancers among retinoblastoma survivors.

Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J.

J Natl Cancer Inst. 2004 Mar 3;96(5):357-63.

PMID:
14996857

Supplemental Content

Support Center